Ceribell, Inc.

Ceribell, Inc. has 2 AI-enabled medical devices on the FDA list. The first decision was on May 23, 2023 and the most recent on December 8, 2025 (Ceribell Delirium Monitor System). Its most common review panel is Neurology (2 devices).